Evidence map›Paper›PMID 30249691›Full record

ArticleAntimicrobial agents and chemotherapy2018

Sophie G Zaloumis, Pengxing Cao, Saber Dini, Miles P Davenport, Deborah Cromer, David S Khoury, Freya J I Fowkes, James M McCaw, Julie A Simpson

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sophie G ZaloumisCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia sophiez@unimelb.edu.au.ORCID 0000-0002-8253-8896
Pengxing CaoSchool of Mathematics and Statistics, University of Melbourne, Melbourne, Australia.
Saber DiniCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
Miles P DavenportInfection Analytics Program, The Kirby Institute, UNSW, Sydney, Australia.
Deborah CromerInfection Analytics Program, The Kirby Institute, UNSW, Sydney, Australia.
David S KhouryInfection Analytics Program, The Kirby Institute, UNSW, Sydney, Australia.
Freya J I FowkesCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
James M McCawCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
Julie A SimpsonCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
The University of Melbourne · AUBurnet Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimalarial treatment currently relies on an artemisinin derivative and a longer-acting partner drug. With the emergence of resistance to the artemisinin derivatives and the potential pressure this exerts on the partner drugs, the impact of resistance to each drug on efficacy needs to be investigated. An

Indexed as

AntimalarialsArtemisininsArtesunateComputer SimulationDrug ResistanceDrug Therapy, CombinationHumansMalaria, FalciparumMefloquineModels, BiologicalPiperazinesPlasmodium falciparumQuinolinesTreatment FailureAntimalarialsArtemisininsartenimolArtesunateMefloquinepiperaquinePiperazinesQuinolinesantimalarial combination therapyartemisinin resistancemalariapartner drug resistancepharmacokinetic-pharmacodynamic modelingwithin-host modeling

Identifiers

PMID30249691
PMCPMC6256805
OpenAlexW2890481261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.